EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions

Thierry Simonart iD, Xuân-Lan Lam Hoai iD

Journal of Clinical Medicine · 18.09.2024 · 13 (18) · 5511

DOI: 10.3390/jcm13185511 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.09.2024. Verfasst von Thierry Simonart und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Delta Hospital, CHIREC, Université Libre de Bruxelles, 1160 Bruxelles, Belgium. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Scabies is a prevalent dermatological condition with significant public health implications. The recent rise in drug-resistant scabies presents new challenges for effective disease management and control.

Methods

A comprehensive literature review was conducted using PubMed, Cochrane Library, and Web of Science. Studies published from 2000 to August 2024 were considered, focusing on those reporting drug-resistant scabies and advancements in treatment approaches.

Results

Clinical studies, in vitro investigations, and case reports show significant resistance of human scabies to permethrin. Main resistance mechanisms involve genetic mutations in the mites’ voltage-gated sodium channels (VGSCs) and enhanced activity or expression of the detoxifying enzyme glutathione S-transferase (GST). Resistance to ivermectin and benzyle benzoate, although suggested by some authors, seems less obvious. The clinical evidence of widespread ivermectin resistance in human scabies infestations is lacking, despite indications of increased tolerance in laboratory settings and anecdotal reports of resistance in patients with crusted scabies. Benzyl benzoate resistance in scabies mites remains unconfirmed.

Conclusions

Permethrin-resistant scabies is an escalating threat requiring new management strategies and updated guidelines. Infection control measures, alternative treatments, and ongoing research into new therapeutics are crucial to mitigate the impact of drug-resistant scabies.

Schlagwörter

Stichwörter der Autor:innen

benzyl benzoateivermectinpermethrinresistancescabies

Autor:innen und Institutionen

  • Department of Dermatology, Delta Hospital, CHIREC, Université Libre de Bruxelles, 1160 Bruxelles, Belgium.
  • Department of Dermatology, St Pierre-Brugmann-HUDERF University Hospitals, Université Libre de Bruxelles, 1000 Brussels, Belgium.

ORCID-Profile: Thierry Simonart, Xuân-Lan Lam Hoai

Zitieren

APA

Simonart, T., & Lam Hoai, X. L. (2024). Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions. Journal of Clinical Medicine, 13(18), 5511. https://doi.org/10.3390/jcm13185511

Vancouver

Simonart T, Lam Hoai XL. Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions. Journal of Clinical Medicine. 2024;13(18):5511. doi:10.3390/jcm13185511

BibTeX
@article{Simonart2024,
  author = {Simonart, Thierry and Lam Hoai, Xuân-Lan},
  title = {Escalating Threat of Drug-Resistant Human Scabies: Current Insights and Future Directions},
  journal = {Journal of Clinical Medicine},
  year = {2024},
  volume = {13},
  number = {18},
  pages = {5511},
  doi = {10.3390/jcm13185511}
}
Kostenlos starten →